Dr Adnan Nagrial

Clinical Senior Lecturer
Westmead Clinical School

Telephone +61 2 9845 5200
Fax +61 2 9845 6391

Map

Keywords

Lung cancer; Cancer; Colorectal cancers

Clinical Specialty

Oncology

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Chin, V., Nagrial, A., Sjoquist, K., O�Connor, C., Chantrill, L., Biankin, A., Scholten, R., Yip, D. (2018). Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database of Systematic Reviews, 3, 1-126. [More Information]
  • Pokorny, A., Chin, V., Nagrial, A., Yip, D., Chantrill, L. (2018). Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future. Internal Medicine Journal, 48(6), 637-644. [More Information]
  • Karikios, D., Chim, L., Martin, A., Nagrial, A., Howard, K., Salkeld, G., Stockler, M. (2017). Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia. Internal Medicine Journal, 47(4), 400-407. [More Information]
  • Vennin, C., Chin, V., Warren, S., Lucas, M., Herrmann, D., Magenau, A., Melenec, P., Walters, S., del Monte-Nieto, G., Conway, J., Jain, R., Weninger, W., Johns, A., Gill, A., et al (2017). Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Science Translational Medicine, 9(384), 1-17. [More Information]
  • Janssen, A., Shaw, T., Nagrial, A., Pene, C., Rabbets, M., Carlino, M., Zachulski, C., Phillips, J., Birnbaum, R., Gandhi, T., Harnett, P. (2016). An Online Learning Module to Increase Self-Efficacy and Involvement in Care for Patients With Advanced Lung Cancer: Research Protocol. JMIR Research Protocols, 5(3), 1-8. [More Information]
  • Bailey, P., Chang, D., Nones, K., Johns, A., Patch, A., Gingras, M., Miller, D., Christ, A., Bruxner, T., Quinn, M., Samra, J., Kench, J., Gill, A., et al (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52. [More Information]
  • Humphrey, E., Su, S., Nagrial, A., Hochgrafe, F., Pajic, M., Lehrbach, G., Parton, R., Yap, A., Horvath, L., Chang, D., et al (2016). Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Molecular and Cellular Proteomics, 15(8), 2671-2685. [More Information]
  • Sabanathan, D., Nagrial, A., Chin, V. (2016). The changing landscape of systemic therapy in advanced pancreatic cancer. Cancer Forum, 40(1), 53-58.
  • Carlino, M., Kwan, V., Miller, D., Saunders, C., Yip, D., Nagrial, A., Tomlinson, J., Grimmond, S., Scolyer, R., Kefford, R., Long, G., et al (2015). New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma. Journal of Clinical Oncology, 33(11), e52-E56. [More Information]
  • Carlino, M., Fung, C., Shahheydari, H., Todd, J., Boyd, S., Irvine, M., Nagrial, A., Scolyer, R., Kefford, R., Long, G., Rizos, H. (2015). Pre-existing MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients. Clinical Cancer Research, 21(1), 98-105. [More Information]
  • Chantrill, L., Nagrial, A., Watson, C., Johns, A., Martyn-Smith, M., Simpson, S., Mead, S., Jones, M., Samra, J., Gill, A., Chin, V., Sebastian, L., Sjoquist, K., Yip, S., Pavlakis, N., Grimison, P., Simes, R., et al (2015). Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial. Clinical Cancer Research, 21(9), 2029-2037. [More Information]
  • Chin, V., Nagrial, A., Chou, A., Biankin, A., Gill, A., Timpson, P., Pajic, M. (2015). Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities. Expert Reviews in Molecular Medicine, 17, 1-14. [More Information]
  • Nagrial, A., Chin, V., Sjoquist, K., Pajic, M., Horvath, L., Biankin, A., Yip, D. (2015). Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials. Critical Reviews in Oncology / Hematology (online), 96(3), 483-497. [More Information]
  • Nagrial, A., Chang, D., Nguyen, N., Johns, A., Chantrill, L., Humphris, J., Chin, V., Samra, J., Gill, A., Pajic, M., Kench, J., et al (2014). Adjuvant chemotherapy in elderly patients with pancreatic cancer. British Journal of Cancer, 110(2), 313-319. [More Information]
  • Humphris, J., Johns, A., Simpson, S., Cowley, M., Pajic, M., Chang, D., Nagrial, A., Chin, V., Chantrill, L., Pinese, M., Gill, A., Samra, J., Kench, J., et al (2014). Clinical and pathologic features of familial pancreatic cancer. Cancer, 120(23), 3669-3675. [More Information]
  • Al-Ejeh, F., Pajic, M., Shi, W., Kalimutho, M., Miranda, M., Nagrial, A., Chou, A., Biankin, A., Grimmond, S., et al (2014). Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research, 20(12), 3187-3197. [More Information]
  • Sjoquist, K., Chin, V., Chantrill, L., O'Connor, C., Hemmings, C., Chang, D., Chou, A., Pajic, M., Johns, A., Nagrial, A., et al (2014). Personalising pancreas cancer treatment: When tissue is the issue. World Journal of Gastroenterology, 20(24), 7849-7863. [More Information]
  • Chou, A., Waddell, N., Cowley, M., Gill, A., Chang, D., Patch, A., Nones, K., Wu, J., Pinese, M., Johns, A., Toon, C., et al (2013). Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Medicine, 5(8), 1-11. [More Information]
  • Chang, D., Jamieson, N., Johns, A., Scarlett, C., Pajic, M., Chou, A., Pinese, M., Humphris, J., Jones, M., Toon, C., Samra, J., Kench, J., Gill, A., et al (2013). Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater. Journal of Clinical Oncology, 31(10), 1348-1356. [More Information]
  • Humphris, J., Chang, D., Johns, A., Scarlett, C., Pajic, M., Jones, M., Colvin, E., Nagrial, A., Chin, V., Chantrill, L., Samra, J., Gill, A., Kench, J., et al (2012). The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Annals of Oncology, 23(7), 1713-1722. [More Information]
  • Nagrial, A., Horvath, L. (2010). Bone disease in prostate cancer. Asia-Pacific Journal of Clinical Oncology, 6(1), 3-4. [More Information]

2018

  • Chin, V., Nagrial, A., Sjoquist, K., O�Connor, C., Chantrill, L., Biankin, A., Scholten, R., Yip, D. (2018). Chemotherapy and radiotherapy for advanced pancreatic cancer. Cochrane Database of Systematic Reviews, 3, 1-126. [More Information]
  • Pokorny, A., Chin, V., Nagrial, A., Yip, D., Chantrill, L. (2018). Metastatic pancreatic ductal adenocarcinoma: diagnosis and treatment with a view to the future. Internal Medicine Journal, 48(6), 637-644. [More Information]

2017

  • Karikios, D., Chim, L., Martin, A., Nagrial, A., Howard, K., Salkeld, G., Stockler, M. (2017). Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia. Internal Medicine Journal, 47(4), 400-407. [More Information]
  • Vennin, C., Chin, V., Warren, S., Lucas, M., Herrmann, D., Magenau, A., Melenec, P., Walters, S., del Monte-Nieto, G., Conway, J., Jain, R., Weninger, W., Johns, A., Gill, A., et al (2017). Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis. Science Translational Medicine, 9(384), 1-17. [More Information]

2016

  • Janssen, A., Shaw, T., Nagrial, A., Pene, C., Rabbets, M., Carlino, M., Zachulski, C., Phillips, J., Birnbaum, R., Gandhi, T., Harnett, P. (2016). An Online Learning Module to Increase Self-Efficacy and Involvement in Care for Patients With Advanced Lung Cancer: Research Protocol. JMIR Research Protocols, 5(3), 1-8. [More Information]
  • Bailey, P., Chang, D., Nones, K., Johns, A., Patch, A., Gingras, M., Miller, D., Christ, A., Bruxner, T., Quinn, M., Samra, J., Kench, J., Gill, A., et al (2016). Genomic analyses identify molecular subtypes of pancreatic cancer. Nature, 531(7592), 47-52. [More Information]
  • Humphrey, E., Su, S., Nagrial, A., Hochgrafe, F., Pajic, M., Lehrbach, G., Parton, R., Yap, A., Horvath, L., Chang, D., et al (2016). Resolution of Novel Pancreatic Ductal Adenocarcinoma Subtypes by Global Phosphotyrosine Profiling. Molecular and Cellular Proteomics, 15(8), 2671-2685. [More Information]
  • Sabanathan, D., Nagrial, A., Chin, V. (2016). The changing landscape of systemic therapy in advanced pancreatic cancer. Cancer Forum, 40(1), 53-58.

2015

  • Carlino, M., Kwan, V., Miller, D., Saunders, C., Yip, D., Nagrial, A., Tomlinson, J., Grimmond, S., Scolyer, R., Kefford, R., Long, G., et al (2015). New RAS-Mutant Pancreatic Adenocarcinoma With Combined BRAF and MEK Inhibition for Metastatic Melanoma. Journal of Clinical Oncology, 33(11), e52-E56. [More Information]
  • Carlino, M., Fung, C., Shahheydari, H., Todd, J., Boyd, S., Irvine, M., Nagrial, A., Scolyer, R., Kefford, R., Long, G., Rizos, H. (2015). Pre-existing MEK1P124 mutations diminish response to BRAF inhibitors in metastatic melanoma patients. Clinical Cancer Research, 21(1), 98-105. [More Information]
  • Chantrill, L., Nagrial, A., Watson, C., Johns, A., Martyn-Smith, M., Simpson, S., Mead, S., Jones, M., Samra, J., Gill, A., Chin, V., Sebastian, L., Sjoquist, K., Yip, S., Pavlakis, N., Grimison, P., Simes, R., et al (2015). Precision Medicine for Advanced Pancreas Cancer: The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) Trial. Clinical Cancer Research, 21(9), 2029-2037. [More Information]
  • Chin, V., Nagrial, A., Chou, A., Biankin, A., Gill, A., Timpson, P., Pajic, M. (2015). Rho-associated kinase signalling and the cancer microenvironment: novel biological implications and therapeutic opportunities. Expert Reviews in Molecular Medicine, 17, 1-14. [More Information]
  • Nagrial, A., Chin, V., Sjoquist, K., Pajic, M., Horvath, L., Biankin, A., Yip, D. (2015). Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials. Critical Reviews in Oncology / Hematology (online), 96(3), 483-497. [More Information]

2014

  • Nagrial, A., Chang, D., Nguyen, N., Johns, A., Chantrill, L., Humphris, J., Chin, V., Samra, J., Gill, A., Pajic, M., Kench, J., et al (2014). Adjuvant chemotherapy in elderly patients with pancreatic cancer. British Journal of Cancer, 110(2), 313-319. [More Information]
  • Humphris, J., Johns, A., Simpson, S., Cowley, M., Pajic, M., Chang, D., Nagrial, A., Chin, V., Chantrill, L., Pinese, M., Gill, A., Samra, J., Kench, J., et al (2014). Clinical and pathologic features of familial pancreatic cancer. Cancer, 120(23), 3669-3675. [More Information]
  • Al-Ejeh, F., Pajic, M., Shi, W., Kalimutho, M., Miranda, M., Nagrial, A., Chou, A., Biankin, A., Grimmond, S., et al (2014). Gemcitabine and CHK1 Inhibition Potentiate EGFR-Directed Radioimmunotherapy against Pancreatic Ductal Adenocarcinoma. Clinical Cancer Research, 20(12), 3187-3197. [More Information]
  • Sjoquist, K., Chin, V., Chantrill, L., O'Connor, C., Hemmings, C., Chang, D., Chou, A., Pajic, M., Johns, A., Nagrial, A., et al (2014). Personalising pancreas cancer treatment: When tissue is the issue. World Journal of Gastroenterology, 20(24), 7849-7863. [More Information]

2013

  • Chou, A., Waddell, N., Cowley, M., Gill, A., Chang, D., Patch, A., Nones, K., Wu, J., Pinese, M., Johns, A., Toon, C., et al (2013). Clinical and molecular characterization of HER2 amplified-pancreatic cancer. Genome Medicine, 5(8), 1-11. [More Information]
  • Chang, D., Jamieson, N., Johns, A., Scarlett, C., Pajic, M., Chou, A., Pinese, M., Humphris, J., Jones, M., Toon, C., Samra, J., Kench, J., Gill, A., et al (2013). Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater. Journal of Clinical Oncology, 31(10), 1348-1356. [More Information]

2012

  • Humphris, J., Chang, D., Johns, A., Scarlett, C., Pajic, M., Jones, M., Colvin, E., Nagrial, A., Chin, V., Chantrill, L., Samra, J., Gill, A., Kench, J., et al (2012). The prognostic and predictive value of serum CA19.9 in pancreatic cancer. Annals of Oncology, 23(7), 1713-1722. [More Information]

2010

  • Nagrial, A., Horvath, L. (2010). Bone disease in prostate cancer. Asia-Pacific Journal of Clinical Oncology, 6(1), 3-4. [More Information]

To update your profile click here. For support on your academic profile contact .